Showing results (11-20 of 131) with videos related to

Sort By:
Pageof 14
BMC Clinical Pharmacology|December 6, 2008
Investigation of the diurnal variation in bone resorption for optimal drug delivery and efficacy in osteoporosis with oral calcitoninM A Karsdal, I Byrjalsen, B J Riis, et al.
BMC Musculoskeletal Disorders|November 21, 2008
Tibolone inhibits bone resorption without secondary positive effects on cartilage degradationM A Karsdal, I Byrjalsen, D J Leeming, et al.
Clinical and Experimental Immunology|February 5, 2008
Oestrogen exhibits type II collagen protective effects and attenuates collagen-induced arthritis in ratsR H Nielsen, C Christiansen, M Stolina, et al.
Current Protein & Peptide Science|November 3, 2011
Disruption of the V-ATPase functionality as a way to uncouple bone formation and resorption - a novel target for treatment of osteoporosisC S Thudium, V K Jensen, M A Karsdal, et al.
Menopause International|October 2, 2012
The pathogenesis of osteoarthritis involves bone, cartilage and synovial inflammation: may estrogen be a magic bullet?M A Karsdal, A C Bay-Jensen, K Henriksen, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 12, 2007
Bone turnover and bone collagen maturation in osteoporosis: effects of antiresorptive therapiesI Byrjalsen, D J Leeming, P Qvist, et al.
Osteoarthritis and Cartilage|January 22, 2011
Oral salmon calcitonin reduces cartilage and bone pathology in an osteoarthritis rat model with increased subchondral bone turnoverR H Nielsen, A-C Bay-Jensen, I Byrjalsen, et al.
Osteoarthritis and Cartilage|September 5, 2008
Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRIE B Dam, I Byrjalsen, M A Karsdal, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|December 3, 2009
Should biochemical markers of bone turnover be considered standard practice for safety pharmacology?K Henriksen, K M Bohren, A C Bay-Jensen, et al.
Bone|October 3, 2006
Strontium ranelate reduces the urinary level of cartilage degradation biomarker CTX-II in postmenopausal womenPeter Alexandersen, M A Karsdal, Per Qvist, et al.
Pageof 14